Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Real Estate - GrossReal Estate - NetReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regency Centers (REGCP) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Regency Centers (REGCP) over the last 17 years, with Q4 2025 value amounting to $120.7 million.

  • Regency Centers' Cash & Equivalents rose 9497.93% to $120.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $120.7 million, marking a year-over-year increase of 9497.93%. This contributed to the annual value of $120.7 million for FY2025, which is 9497.93% up from last year.
  • According to the latest figures from Q4 2025, Regency Centers' Cash & Equivalents is $120.7 million, which was up 9497.93% from $205.6 million recorded in Q3 2025.
  • Regency Centers' 5-year Cash & Equivalents high stood at $362.7 million for Q3 2021, and its period low was $43.1 million during Q2 2023.
  • In the last 5 years, Regency Centers' Cash & Equivalents had a median value of $117.7 million in 2024 and averaged $136.9 million.
  • As far as peak fluctuations go, Regency Centers' Cash & Equivalents crashed by 8109.24% in 2021, and later skyrocketed by 23767.37% in 2024.
  • Over the past 5 years, Regency Centers' Cash & Equivalents (Quarter) stood at $95.0 million in 2021, then dropped by 27.62% to $68.8 million in 2022, then soared by 32.83% to $91.4 million in 2023, then tumbled by 32.26% to $61.9 million in 2024, then surged by 94.98% to $120.7 million in 2025.
  • Its Cash & Equivalents stands at $120.7 million for Q4 2025, versus $205.6 million for Q3 2025 and $154.8 million for Q2 2025.